JP6170314B2 - Antioxidants with fu extract - Google Patents
Antioxidants with fu extract Download PDFInfo
- Publication number
- JP6170314B2 JP6170314B2 JP2013042626A JP2013042626A JP6170314B2 JP 6170314 B2 JP6170314 B2 JP 6170314B2 JP 2013042626 A JP2013042626 A JP 2013042626A JP 2013042626 A JP2013042626 A JP 2013042626A JP 6170314 B2 JP6170314 B2 JP 6170314B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- present
- hair
- plant
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims description 58
- 239000003963 antioxidant agent Substances 0.000 title claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- 239000002537 cosmetic Substances 0.000 claims description 39
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 210000003491 skin Anatomy 0.000 claims description 26
- 230000003078 antioxidant effect Effects 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 235000006708 antioxidants Nutrition 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 17
- 210000004209 hair Anatomy 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 15
- 230000008810 intracellular oxidative stress Effects 0.000 claims description 15
- 235000015512 Liquidambar formosana Nutrition 0.000 claims description 13
- 241000893545 Liquidambar formosana Species 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 13
- 239000003112 inhibitor Substances 0.000 claims description 9
- 238000001727 in vivo Methods 0.000 claims description 7
- 210000004761 scalp Anatomy 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 230000003712 anti-aging effect Effects 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 230000003796 beauty Effects 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 229930003799 tocopherol Natural products 0.000 claims description 4
- 235000010384 tocopherol Nutrition 0.000 claims description 4
- 229960001295 tocopherol Drugs 0.000 claims description 4
- 230000001256 tonic effect Effects 0.000 claims description 3
- 210000004207 dermis Anatomy 0.000 claims description 2
- 210000002615 epidermis Anatomy 0.000 claims description 2
- 210000000434 stratum corneum Anatomy 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 description 31
- 241000196324 Embryophyta Species 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 18
- 241000223218 Fusarium Species 0.000 description 18
- -1 ascorbyl 2,3,5,6-tetrahexyldecanoate Chemical compound 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003642 reactive oxygen metabolite Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 10
- 230000003834 intracellular effect Effects 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 230000003779 hair growth Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000419 plant extract Substances 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 229940042585 tocopherol acetate Drugs 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 235000019645 odor Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 4
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 239000001886 liquidambar orientalis Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 241000208682 Liquidambar Species 0.000 description 2
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000008585 Pinus thunbergii Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000008308 lipophilic cream Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- IEKHISJGRIEHRE-UHFFFAOYSA-N 16-methylheptadecanoic acid;propan-2-ol;titanium Chemical compound [Ti].CC(C)O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O IEKHISJGRIEHRE-UHFFFAOYSA-N 0.000 description 1
- DJHVICOPLAQAGI-UHFFFAOYSA-N 18-methylnonadecan-1-amine Chemical compound CC(C)CCCCCCCCCCCCCCCCCN DJHVICOPLAQAGI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000005638 Austrian pine Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- YQUXMATUCUXMFF-UHFFFAOYSA-N CCCC(C1=C(C(=C(C(=C1OC(=O)C2=CC=CC=C2)C)C)C)C)(N(CC)CC)O Chemical compound CCCC(C1=C(C(=C(C(=C1OC(=O)C2=CC=CC=C2)C)C)C)C)(N(CC)CC)O YQUXMATUCUXMFF-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000723438 Cercidiphyllum japonicum Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000272185 Falco Species 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 229940086609 Lipase inhibitor Drugs 0.000 description 1
- 235000015513 Liquidambar acalycina Nutrition 0.000 description 1
- 241000893548 Liquidambar acalycina Species 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- 241000893513 Liquidambar orientalis Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008565 Pinus banksiana Nutrition 0.000 description 1
- 244000019397 Pinus jeffreyi Species 0.000 description 1
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 241000218686 Pinus thunbergii Species 0.000 description 1
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 240000002871 Tectona grandis Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- LITUBCVUXPBCGA-UHFFFAOYSA-N ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)C1OC(=O)C(O)=C1O LITUBCVUXPBCGA-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、フウ属植物の抽出物を有効成分とする、抗酸化剤、特に生体内で有効な抗酸化剤に関する。本発明は、化粧品製造分野等で有用である。 The present invention relates to an antioxidant, particularly an antioxidant effective in vivo, comprising an extract of a genus Fusarium as an active ingredient. The present invention is useful in the cosmetics manufacturing field and the like.
フウ（楓、学名：Liquidambar formosana）はフウ科（クロンキスト体系ではマンサク科）フウ属の落葉高木である。サンカクバフウ（三角葉楓）、タイワンフウ（台湾楓）、イガカエデ（伊賀楓）、カモカエデ（賀茂楓）、オカツラ（男桂）とも称されることがある。フウの成熟果実を乾燥したものはロロツウ（路路通）として漢方薬等として、アレルギー性疾患、打撲捻挫等に用いられている。 Fu (Squirrel, scientific name: Liquidumbar formosana) is a deciduous tree of the genus Fu (family witch hazel in the Clonquist system). Sangakubafu (triangle leaf moth), Taiwanfu (Taiwan moth), Ika maple (Iga moth), Kamoka maple (Kamo niece), Okatsura (Male katsura). The dried fruit of mature fu is used as a herbal medicine, such as rorotsu (rochi-dori), for allergic diseases, bruise sprains and the like.
特許文献1は、ヌクレオチドおよび／または生理的に許容されるその塩と、ロロツウを含む天然物群から選ばれる1種または2種以上の活血薬を有効成分として含有する、人体過剰対応抑制剤からなるアレルギー性疾患治療薬を開示する。また、特許文献2は、フウを含む群から選ばれる植物の水抽出物を1種以上、またはそれらから選ばれる植物のアルコール抽出物含有するリパーゼ阻害剤を開示する。さらに特許文献3は、ロロツウまたはその有機溶剤抽出物を有効成分とするドーパオキシダーゼ活性抑制剤、メラニン生成抑制剤、およびロロツウまたはその有機溶剤抽出物を有効成分とする美白剤を開示する。 Patent Document 1 discloses a human excess response inhibitor containing, as active ingredients, nucleotides and / or physiologically acceptable salts thereof and one or more active blood agents selected from natural products including rorotsu. Disclosed is a therapeutic agent for allergic diseases. Patent Document 2 discloses a lipase inhibitor containing one or more water extracts of plants selected from the group containing fu or an alcohol extract of plants selected from them. Further, Patent Document 3 discloses a dopa oxidase activity inhibitor, melanin production inhibitor containing rorotsu or an organic solvent extract thereof as an active ingredient, and a whitening agent containing rorotsu or an organic solvent extract thereof as an active ingredient.
一方、細胞の酸化は、皮膚の老化の原因の一つとして知られている。また抗酸化作用を有する成分を、養毛のために利用することも試みられている（特許文献4および5）。 On the other hand, cell oxidation is known as one of the causes of skin aging. In addition, attempts have been made to use components having an antioxidant effect for hair restoration (Patent Documents 4 and 5).
本発明者らは、抗酸化作用を有する植物由来の成分について検討してきた。とりわけ、生体内において有効に酸化ストレスを低減させる成分について鋭意検討してきた。その結果、フウ抽出物が優れた抗酸化能を有することを見出し、本発明を完成した。 The present inventors have studied a plant-derived component having an antioxidant action. In particular, it has been intensively studied on components that effectively reduce oxidative stress in vivo. As a result, the present inventors have found that a fu extract has an excellent antioxidant ability and completed the present invention.
本発明は、以下を提供する。
[1]フウ属の植物の抽出物を有効成分とする、抗酸化剤。
[2]フウ属の植物の抽出物を有効成分とする、生体内抗酸化剤。
[3]フウ属の植物の抽出物を有効成分とする、細胞内酸化ストレス抑制剤。
[4]フウ属の植物が、フウ(Liquidambar formosana)である、[1]〜[3]のいずれか一に記載の剤。
[5]抽出物が、フウ属の植物の幹および／または葉の抽出物である、[1]〜[4]のいずれか一に記載の剤。
[6]抽出物が、水、親水性有機溶媒、またはそれらの混合物を溶媒として得られたものである、[1]〜[5]のいずれか一に記載の剤。
[7]アスコルビン酸もしくはその誘導体、および／またはトコフェロールもしくはその誘導体をさらに含む、[1]〜[6]のいずれか一に記載の剤。
[8]抗老化用の、皮膚外用剤または化粧料に添加するための、[1]〜[7]のいずれか一に記載の剤。
[9]整髪用、養毛用もしくはヘアトニックとして用いる皮膚外用剤または化粧料に添加するための、[1]〜[8]のいずれか一に記載の剤。
[10]フウ属の植物の抽出物を、皮膚へ適用し、角層、表皮または真皮の酸化ストレスを抑制する工程を含む、美容方法。
The present invention provides the following.
[1] An antioxidant comprising an extract of a plant of the genus Fusarium as an active ingredient.
[2] An in vivo antioxidant comprising an extract of a plant of the genus Fusarium as an active ingredient.
[3] An intracellular oxidative stress inhibitor comprising an extract of a genus Fusarium as an active ingredient.
[4] The agent according to any one of [1] to [3], wherein the plant of the genus Fuhu is Fumu (Liquidambar formosana).
[5] The agent according to any one of [1] to [4], wherein the extract is an extract of a stem and / or leaf of a plant belonging to the genus Fusarium.
[6] The agent according to any one of [1] to [5], wherein the extract is obtained using water, a hydrophilic organic solvent, or a mixture thereof as a solvent.
[7] The agent according to any one of [1] to [6], further comprising ascorbic acid or a derivative thereof and / or tocopherol or a derivative thereof.
[8] The agent according to any one of [1] to [7], which is added to a skin external preparation or cosmetic for anti-aging.
[9] The agent according to any one of [1] to [8], which is added to a skin external preparation or cosmetic used for hair styling, hair nourishing, or hair tonic.
[10] A cosmetic method comprising a step of applying an extract of a plant of the genus Fusarium to the skin to suppress oxidative stress in the stratum corneum, epidermis or dermis.
以下、本発明について詳細に説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。また、%で表記する数値は、特に記載した場合を除き、質量を基準にした値である。 Hereinafter, the present invention will be described in detail. In the present specification, “to” means a range including numerical values before and after. In addition, numerical values expressed in% are values based on mass, unless otherwise specified.
本発明の抗酸化剤または細胞内酸化ストレス抑制剤（以下、「本発明の剤」ということがある。）は、フウ科（クロンキスト体系ではマンサク科）フウ属に属する植物からの抽出物を有効成分とする。 The antioxidant or intracellular oxidative stress inhibitor of the present invention (hereinafter sometimes referred to as “the agent of the present invention”) is an effective extract from a plant belonging to the genus Fusarae (Mansacaceae in the Clonquist family). Ingredients.
本発明に用いられるフウ属の植物は、特に記載した場合を除き、種に限定はなく、いずれの種であってもよい。フウ属の植物には、フウ（Liquidambar formosana）、モミジバフウ（Liquidambar styraciflua）、欠萼楓香樹（Liquidambar acalycina）、スタイラックス（Liquidambar orientalis）などが含まれる。本発明においては、フウ属の植物として、好ましくはフウ（Liquidambar formosana）を用いる。 The plant of the genus Fusarium used in the present invention is not limited to a species, except for the case described in particular, and may be any species. Plants of the genus Fuzhou include Fu (Liquidambar formosana), Momijibafu (Liquidambar styraciflua), Liquidambar acalycina, and Stylax (Liquidambar orientalis). In the present invention, preferably Fu (Liquidambar formosana) is used as a plant belonging to the genus Fusarium.
本発明に用いられるフウ属の植物の部位は、特に記載した場合を除き、植物の、全体またはその一部を指す。「一部」には、幹（樹皮、木部を含む。）、葉（葉身、葉柄、托葉を含む。）、根、花（花弁、萼片を含む。）、蕊、果実、種子が含まれる。本発明においては、フウ属植物として、好ましくは樹皮、木部、葉、またはそれらの混合部位、より好ましくは幹または葉を用いる。本発明においては、ロロツウを除くフウ属の植物の一部を用いてもよい。 The part of the plant of the genus Fusarium used in the present invention refers to the whole plant or a part thereof, unless otherwise specified. “Part” includes trunk (including bark and xylem), leaf (including leaf blade, petiole, and bamboo leaf), root, flower (including petal and sepal), persimmon, fruit, and seed. included. In the present invention, bark, xylem, leaves, or a mixed part thereof, more preferably a trunk or a leaf, is preferably used as the Fucus plant. In the present invention, a part of the plant belonging to the genus Fusara excluding Lorotsu may be used.
本発明の抽出原料としてのフウ属植物は、生のものであってもよく、乾燥物等であってもよい。抽出工程に供する前に、抽出が効率的に行われるように、裁断・粉砕等の前処理を行ってもよい。 The plant of the genus Fusarium as the extraction raw material of the present invention may be raw or dried. Before being subjected to the extraction step, pretreatment such as cutting and pulverization may be performed so that extraction is performed efficiently.
本発明で「抽出物」というときは、特に記載した場合を除き、原料フウ属植物を抽出溶媒に浸漬して得られた液から固形物を除いたものそのものであってもよく、該液を、濃縮、乾燥等したものであってもよい。抽出物の形態は、液状、ペースト状、ゲル状、固体状、粉末状等いずれでもあり得る。また、フウ属植物の圧搾汁そのものであってもよく、該圧搾汁を、濃縮、乾燥等したものであってもよい。固体状または粉末状とするためには、液状物を、乾燥工程に供することができ、蒸発乾固させて固体状としてもよく、スプレードライにより乾燥させて粉末としてもよく、また凍結乾燥して凍結乾燥物としてもよい。 In the present invention, the term “extract” refers to a liquid obtained by immersing a raw plant belonging to the genus Fusarium in an extraction solvent, unless otherwise specified. , Concentrated, dried, etc. The form of the extract can be any of liquid, paste, gel, solid, powder and the like. Moreover, the pressing juice itself of the genus Fusarium may be sufficient, and what was concentrated, dried, etc. may be sufficient as this pressing juice. In order to obtain a solid or powder form, the liquid can be subjected to a drying process, and may be evaporated to dryness to form a solid, or may be dried by spray drying to form a powder, or may be freeze-dried. It may be a lyophilized product.
抽出物を得るための抽出溶媒は特に限定されない。例えば、水、低級アルコール類（メタノール、エタノール、1-プロパノール、2-プロパノール、1-ブタノール、2-ブタノール等）、多価アルコール類（グリセロール、プロピレングリコール、1,3-ブチレングリコール（BG）等）、ケトン類（アセトン、メチルケトン等）、エーテル類（ジエチルエーテル、テトラヒドロフラン等）、酢酸エチル等のエステル類；ヘキサン等からなる群より選択される一種または二種以上を用いることができる。好ましくは水系溶媒、具体的には水、親水性有機溶媒（例えば、メタノール、エタノール、グリセロール、1,3-ブチレングリコール）、またはそれらの混合物を抽出溶媒として用いる。混合溶媒を用いる場合、その比率も特に限定されない。本発明に好適に用いることのできる溶媒の例は、水、またはエタノール、グリセロールおよび1,3-ブチレングリコールからなる群より選択される1種以上と水との混合溶媒であり、このとき有機溶媒：水の質量比は、1〜99：99〜1、好ましくは10〜90：90〜10、より好ましくは30〜70：70〜30、例えば50：50である。イオン交換樹脂処理等によって精製することができる。 The extraction solvent for obtaining the extract is not particularly limited. For example, water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), polyhydric alcohols (glycerol, propylene glycol, 1,3-butylene glycol (BG), etc. ), Ketones (acetone, methyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, etc.), esters such as ethyl acetate; one or more selected from the group consisting of hexane and the like can be used. Preferably, an aqueous solvent, specifically water, a hydrophilic organic solvent (for example, methanol, ethanol, glycerol, 1,3-butylene glycol), or a mixture thereof is used as the extraction solvent. When using a mixed solvent, the ratio is not particularly limited. Examples of the solvent that can be suitably used in the present invention are water or a mixed solvent of water and one or more selected from the group consisting of ethanol, glycerol, and 1,3-butylene glycol. : The mass ratio of water is 1 to 99:99 to 1, preferably 10 to 90:90 to 10, more preferably 30 to 70:70 to 30, for example 50:50. It can be purified by ion exchange resin treatment or the like.
抽出操作は、原料フウ属植物を室温または加温下で、溶媒中に浸漬することによって実施できる。原料フウ属植物と溶媒との比は、当業者であれば適宜設計することができるが、例えば、フウ属植物原料1質量部に対する溶媒量は、原料が十分に浸漬できる量であればよく、0.5質量部以上であることが好ましく、1質量部以上であることがより好ましく、2質量部以上であることがより好ましい。溶媒量の上限は、経済的な観点から定めることもでき、原料1質量部に対する溶媒量として、例えば、100質量部以下とすることができ、50質量部以下とすることが好ましく、20質量部以下とすることがより好ましい。抽出温度および期間もまた、当業者であれば適宜設計でき、室温または加温下で、1時間〜数か月、好ましくは6時間〜1週間、より好ましくは12時間〜3日間かけて、実施できる。抽出はまた、水蒸気蒸留の方法に拠ってもよい。抽出物が圧搾汁である場合、一般的な方法で調製することができる。例えば、洗浄した原料を、必要に応じpHを調製して破砕し、得られた破砕物に必要であれば酵素処理を施し、固形物を除くことによる。 The extraction operation can be carried out by immersing the raw plant species in a solvent at room temperature or under heating. The ratio of the raw material genus plant and the solvent can be appropriately designed by those skilled in the art, for example, the amount of the solvent relative to 1 part by mass of the genus Fusarium plant material may be an amount that the raw material can be sufficiently immersed, The amount is preferably 0.5 parts by mass or more, more preferably 1 part by mass or more, and more preferably 2 parts by mass or more. The upper limit of the amount of solvent can also be determined from an economic point of view, as the amount of solvent relative to 1 part by weight of the raw material, for example, can be 100 parts by weight or less, preferably 50 parts by weight or less, 20 parts by weight More preferably, it is as follows. The extraction temperature and period can also be appropriately designed by those skilled in the art, and are carried out at room temperature or under heating for 1 hour to several months, preferably 6 hours to 1 week, more preferably 12 hours to 3 days. it can. Extraction may also depend on the method of steam distillation. When the extract is pressed juice, it can be prepared by a general method. For example, the washed raw material is crushed by adjusting the pH as necessary, and the obtained crushed material is subjected to an enzyme treatment if necessary to remove solids.
植物からの抽出物は特有の匂い、着色を有していることがある。また、経時的に変臭、変色が起きたり沈殿が析出したりするなど安定性が乏しいことがある。抽出物は、目的の活性の低下を招かない範囲で脱色、脱臭等を目的とする精製を行ってもよい。そのための方法としては、例えば活性炭処理、吸着樹脂処理、イオン交換樹脂処理がある。一般に、化粧料は、直接、皮膚や頭髪に塗布し、比較的長い時間塗布した状態を保つとともに、ほぼ毎日連用するものであり、さらに香りは心理的・精神的効果をもたらすことから、化粧料において、香りの影響は非常に大きく、原料成分の臭いには他分野の製品に比べて留意を要する。また外観にも留意を要する。本発明者らの検討によると、実施例で製造したフウ植物抽出物はいずれも、化粧料に添加して用いるのに適した匂い、色であり、化粧料成分としての安定性も期待できるものであった。 Plant extracts may have a characteristic odor and color. Moreover, the stability may be poor, for example, odor or discoloration may occur over time or precipitation may occur. The extract may be purified for the purpose of decolorization, deodorization and the like within a range that does not cause a decrease in the target activity. As a method therefor, there are, for example, activated carbon treatment, adsorption resin treatment, and ion exchange resin treatment. In general, cosmetics are applied directly to the skin and hair, and remain applied for a relatively long time, and are used almost every day. Furthermore, the fragrance has a psychological and mental effect. However, the influence of the scent is very large, and the odor of the raw material components requires attention compared to products in other fields. Also pay attention to the appearance. According to the study by the present inventors, all the plant plant extracts produced in the examples have odors and colors suitable for use in cosmetics and can be expected to be stable as cosmetic ingredients. Met.
本発明は、フウ属の植物からの抽出物を、抗酸化剤（特に生体内抗酸化剤）または細胞内酸化ストレス抑制剤の有効成分として用いる。本発明で「生体内」というときは、経皮吸収された送達先、例えば細胞間および細胞内も含む。本発明で「細胞」というときは、特に記載した場合を除き、皮膚（頭皮も含む。）由来の細胞を含む。 In the present invention, an extract from a plant of the genus Fusarium is used as an active ingredient of an antioxidant (particularly an in vivo antioxidant) or an intracellular oxidative stress inhibitor. In the present invention, the term “in vivo” includes delivery destinations absorbed percutaneously, for example, between cells and cells. In the present invention, the term “cell” includes cells derived from skin (including scalp) unless otherwise specified.
ある成分の抗酸化能または細胞内酸化ストレス抑制能の有無またはその程度は、当業者であれば、この分野で慣用されている手法を用いて評価できる。細胞内ストレス抑制能は、典型的には、本明細書の実施の項に記載した方法に基づき、細胞内ストレス消去率（％）またはIC50値として表し、比較・評価することができる。 A person skilled in the art can evaluate the presence or absence of an antioxidant ability or an ability to suppress intracellular oxidative stress by a method commonly used in this field. The ability to suppress intracellular stress is typically expressed as an intracellular stress elimination rate (%) or an IC 50 value based on the method described in the implementation section of this specification, and can be compared and evaluated.
本発明者らの検討によると、抗酸化能を有する成分であっても、皮膚外用剤や化粧料の場合、経皮的に生体内に取り込まれない場合は意図した効果を発揮できない。生体内に取り込まれても細胞に対して毒性を有する場合等には、意図した効果を発揮することができず、皮膚外用剤または化粧料における有効成分たり得ない。そのためin vitro試験で抗酸化を確認するのではなく、細胞内酸化ストレス抑制能を確認することが重要である。細胞内酸化ストレス抑制能が確認されている本発明の有効成分は、生体内において、細胞外マトリックス（例えば、コラーゲン、エラスチンなどの繊維性蛋白質；ヒアルロン酸（ヒアルロナン）、コンドロイチン硫酸などのグリコサミノグリカンとプロテオグリカン；フィブロネクチン、ラミニンなどの細胞接着性蛋白質）の機能維持のために作用しうる。また本発明の有効成分は、細胞自体および細胞内において、細胞膜、細胞内の組織、細胞核内の遺伝子の機能維持のために作用しうる。なお、本発明で細胞内酸化ストレスに関し、「抑制」というときは、特に記載した場合を除き、細胞内において、活性酸素種（ROS）の発生を抑制すること、発生したROS量を低下させることを含む。ROSの発生抑制またはROS量の低下は、有効成分の直接的な抗酸化作用か、または有効成分が細胞内のSOD（スーパーオキサイドディスムターゼ）、カタラーゼ、グルタチオンペルオキシダーゼなどの抗酸化酵素群を活性化することよる間接的な作用により、生じうる。 According to the study by the present inventors, even if it is a component having antioxidant ability, in the case of an external preparation for skin and cosmetics, the intended effect cannot be exhibited unless it is percutaneously taken into the living body. If it is toxic to cells even when taken into the living body, the intended effect cannot be exerted, and it cannot be an active ingredient in a skin external preparation or cosmetic. Therefore, it is important to confirm the ability to suppress intracellular oxidative stress rather than confirming antioxidants by in vitro tests. The active ingredient of the present invention that has been confirmed to inhibit intracellular oxidative stress is an extracellular matrix (for example, fibrous proteins such as collagen and elastin; glycosamino such as hyaluronic acid (hyaluronan) and chondroitin sulfate). It can act to maintain the function of glycans and proteoglycans; cell adhesion proteins such as fibronectin and laminin). In addition, the active ingredient of the present invention can act for maintaining the function of a cell membrane, a tissue in a cell, and a gene in a cell nucleus in the cell itself and in the cell. In addition, regarding the intracellular oxidative stress in the present invention, when it is referred to as “suppression”, unless otherwise specified, it suppresses the generation of reactive oxygen species (ROS) in the cell and reduces the amount of generated ROS. including. Suppression of ROS generation or reduction of ROS amount may be the direct antioxidant action of the active ingredient, or the active ingredient activates intracellular antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase This can be caused by an indirect action.
本発明で「剤」というときは、特に記載した場合を除き、フウ属植物抽出物自体であることもあり、抽出物に、希釈剤、安定化剤、酸化防止剤、防腐剤等の添加物を添加した、抽出物と添加物とからなるものであることもある。本発明の剤には、既存の皮膚外用剤、化粧料は含まれない。 In the present invention, the term “agent” may be a Fusarium plant extract itself unless otherwise specified, and the extract may contain additives such as diluents, stabilizers, antioxidants, and preservatives. It may be composed of an extract and an additive to which is added. The agent of the present invention does not include existing skin external preparations and cosmetics.
本発明の剤は、フウ属植物抽出物を、本明細書の実施例で示した方法で得た乾燥物として、例えば0.001％以上含むことができ、0.01％以上含むことが好ましく、0.1％以上含むことがより好ましく、1.0％以上含むことがより好ましい。実施例とは異なる抽出物を用いる場合も、同様に設計でき、また液状の抽出物を用いる場合は、固形分を基準に、本明細書の実施例で示した方法で得た乾燥物に当するする量を計算して、設計できる。 The agent of the present invention can contain, for example, 0.001% or more, preferably 0.01% or more, and preferably 0.1% or more of a Fusarium plant extract as a dry product obtained by the method shown in the examples of the present specification. More preferably, it is more preferably 1.0% or more. When an extract different from the examples is used, the design can be made in the same manner. When a liquid extract is used, a dry product obtained by the method shown in the examples of the present specification is used based on the solid content. You can design by calculating the amount to be done.
本発明の剤は、皮膚外用剤または化粧料に添加して用いることができる。皮膚外用剤には、本発明の剤のうち、特に皮膚外用に適した形態のものが含まれる。化粧料には、化粧品および医薬部外品が含まれ、また基礎化粧品、メイクアップ化粧品、ボディ化粧品、頭髪用化粧品、頭皮用化粧品、薬用化粧品、浴用剤、薬用化粧品、育毛剤が含まれる。 The agent of the present invention can be used by adding to a skin external preparation or cosmetic. Examples of the external preparation for skin include those of the present invention that are particularly suitable for external use on the skin. Cosmetics include cosmetics and quasi-drugs, and also include basic cosmetics, makeup cosmetics, body cosmetics, hair cosmetics, scalp cosmetics, medicinal cosmetics, bath preparations, medicinal cosmetics, and hair restorers.
皮膚外用剤または化粧料に、本発明の剤が添加される場合、その含量は、適宜とすることができる。例えば、フウ抽出物を本明細書の実施例で示した方法で得た乾燥物として、0.00001％以上含むようにすることができ、0.0001％以上含むことが好ましく、0.001％以上含むことがより好ましい。より高い効果を長期間維持しうるとの観点からは、0.01％以上含むことが好ましく、0.1％以上含むことがさらに好ましい。また、いずれの場合であっても、上限値は、経済性、溶解性、安定性、有効成分に起因する色または匂い等を考慮して適宜定めることができる。例えば、20％以下とすることができ、10％以下とすることが好ましく、5％以下とすることがより好ましい。実施例とは異なる抽出物を用いる場合も、同様に設計でき、また液状の抽出物を用いる場合は、固形分を基準に、本明細書の実施例で示した方法で得た乾燥物に相当する量を計算して、設計できる。 When the agent of the present invention is added to a skin external preparation or cosmetic, the content thereof can be appropriately determined. For example, the dry matter obtained by the method shown in the examples of the present specification can contain 0.00001% or more, preferably 0.0001% or more, and more preferably 0.001% or more. . From the viewpoint that a higher effect can be maintained for a long period of time, the content is preferably 0.01% or more, and more preferably 0.1% or more. In any case, the upper limit value can be appropriately determined in consideration of economy, solubility, stability, color or odor resulting from the active ingredient, and the like. For example, it can be 20% or less, preferably 10% or less, and more preferably 5% or less. When an extract different from the examples is used, the design can be made in the same manner. When a liquid extract is used, it corresponds to the dried product obtained by the method shown in the examples of this specification based on the solid content. The amount to be calculated can be designed.
本発明の好ましい態様においては、有効成分としてのフウ属植物抽出物は、アスコルビン酸またはその誘導体、および／またはトコフェロール（d-α-トコフェロール、またはdl-α-トコフェロール）若しくはその誘導体と併用される。併用とは、一緒に用いることであり、典型的には、一の剤または組成物中に双方を含んだものを用いることであるが、それぞれを別剤（または別組成物）として、同時に、または順に使用することを含む。 In a preferred embodiment of the present invention, the Fusarium plant extract as an active ingredient is used in combination with ascorbic acid or a derivative thereof and / or tocopherol (d-α-tocopherol or dl-α-tocopherol) or a derivative thereof. . The combined use is to use together, and is typically to use both in one agent or composition, but each as a separate agent (or another composition), at the same time, Or use in order.
本発明で「誘導体」というときは、特に記載した場合を除き、塩、エステル、または配糖体を含み、皮膚外用剤または化粧料として許容されるものをいう。水溶性であっても油溶性であってもよい。アスコルビン酸誘導体の例は、6-ステアリン酸アスコルビル、6-パルミチン酸アスコルビル、2,6-ジパルミチン酸アスコルビル、2,3,5,6-テトラヘキシルデカン酸アスコルビル、アスコルビル／トコフェリル）リン酸K、アスコルビン酸-2-硫酸2Na、アスコルビン酸Na、アスコルビン酸-2-リン酸Mg、アスコルビン酸-2-リン酸Na、アスコルビル-2-グルコシドである。中でもアスコルビン酸-2-リン酸Mg、アスコルビン酸-2-リン酸Na、アスコルビル-2-グルコシドが好ましく、アスコルビル-2-グルコシドが特に好ましい。 In the present invention, “derivative” refers to a salt, ester, or glycoside that is acceptable as an external skin preparation or cosmetic, unless otherwise specified. It may be water-soluble or oil-soluble. Examples of ascorbic acid derivatives are ascorbyl 6-stearate, ascorbyl 6-palmitate, ascorbyl 2,6-dipalmitate, ascorbyl 2,3,5,6-tetrahexyldecanoate, ascorbyl / tocopheryl) phosphate K, ascorbine Acid-2-sulfuric acid 2Na, ascorbic acid Na, ascorbic acid-2-phosphate Mg, ascorbic acid-2-phosphate Na, ascorbyl-2-glucoside. Among them, ascorbic acid-2-phosphate Mg, ascorbic acid-2-phosphate Na and ascorbyl-2-glucoside are preferable, and ascorbyl-2-glucoside is particularly preferable.
トコフェロール誘導体の例は、酢酸トコフェロール（酢酸d-α-トコフェロールまたは酢酸dl-α-トコフェロール）、ニコチン酸トコフェロール（ニコチン酸d-α-トコフェロール、ニコチン酸dl-α-トコフェロール）、トコフェリルリン酸Na、アスコルビル／トコフェリルリン酸K、マレイン酸アスコルビルトコフェリンである。中でも酢酸トコフェロール、ニコチン酸トコフェロールが好ましく、酢酸トコフェロールが特に好ましい。 Examples of tocopherol derivatives are tocopherol acetate (d-α-tocopherol acetate or dl-α-tocopherol acetate), tocopherol nicotinate (d-α-tocopherol nicotinate, dl-α-tocopherol nicotinate), tocopheryl phosphate Na Ascorbyl / tocopheryl phosphate K, ascorbyl tocopherin maleate. Of these, tocopherol acetate and tocopherol nicotinate are preferable, and tocopherol acetate is particularly preferable.
併用の際の各成分それぞれの配合量や比は、当業者であれば適宜設定できる。併用の場合の、フウ属植物抽出物と併用成分との比は、フウ属植物抽出物固形分（本明細書の実施例で示した方法で得た乾燥物に相当する量）1質量部に対し、0.0025〜25,000質量部とすることができ、0.025〜2,500質量部とすることが好ましく、0.25〜250質量部とすることがより好ましい。 Those skilled in the art can appropriately set the blending amount and ratio of each component in the combined use. In the case of the combined use, the ratio of the extract of the genus plant to the combined component is 1 part by mass of the solid content of the genus plant extract (the amount corresponding to the dried product obtained by the method shown in the examples of the present specification). On the other hand, it may be 0.0025 to 25,000 parts by mass, preferably 0.025 to 2,500 parts by mass, and more preferably 0.25 to 250 parts by mass.
本発明の皮膚外用剤または化粧料（これらをまとめて「本発明の組成物」ということもある。）は、本発明の剤の効果を損なわない範囲で、化粧料または医薬として許容される種々の機能性の成分を配合することができる。このような成分の例は、美白剤、紫外線防御剤、抗菌剤、抗炎症剤、細胞賦活剤、活性酸素除去剤、保湿剤、皮膚を清浄にする成分、ニキビ、アセモを防ぐ成分である。 The external preparation for skin or cosmetics of the present invention (these may be collectively referred to as “the composition of the present invention”) are variously acceptable as cosmetics or pharmaceuticals as long as the effects of the agent of the present invention are not impaired. These functional ingredients can be blended. Examples of such ingredients are whitening agents, UV protection agents, antibacterial agents, anti-inflammatory agents, cell activators, active oxygen scavengers, moisturizers, skin cleansing ingredients, acne and acemo prevention ingredients.
本発明の組成物には、本発明の効果を損なわない範囲で、本発明の剤以外に、化粧料または医薬として許容される、種々の添加物を配合することができる。この例は、水（精製水、温泉水、海洋深層水等）、界面活性剤（乳化剤、可溶化剤、懸濁化剤、安定剤等）、酸化防止剤、防腐剤、ゲル化剤、アルコール類、皮膜形成剤、着色料、香料、消臭剤、塩類、pH調整剤、清涼剤、キレート剤、角質溶解剤、酵素、ビタミン類等がある。 In the composition of the present invention, various additives acceptable as cosmetics or pharmaceuticals can be blended in addition to the agent of the present invention within a range not impairing the effects of the present invention. Examples of this are water (purified water, hot spring water, deep sea water, etc.), surfactants (emulsifiers, solubilizers, suspending agents, stabilizers, etc.), antioxidants, preservatives, gelling agents, alcohol , Film forming agents, colorants, fragrances, deodorants, salts, pH adjusters, refreshing agents, chelating agents, keratolytic agents, enzymes, vitamins and the like.
本発明の組成物はまた、その使用目的に応じて、固形剤、半固形剤、液剤等の各種剤形の組成物に調製することができる。より具体的には、本発明の組成物は、基礎化粧品として、クレンジング、洗顔料、化粧水、乳液、クリーム、マッサージ製品、パック製品、美容液・ジェル、リップケア製品等；ベースメイク化粧品として、ファンデーション、フェイスパウダー、化粧下地、コンシーラー等；ポイントメイク化粧品として、口紅、リップグロス・ライナー、チーク製品、アイシャドウ、アイライナー、マスカラ、アイブロウ製品等；ボディ用化粧品として石鹸、液体洗浄料、日焼け止めクリーム、入浴剤等；頭髪用化粧品または頭皮用化粧品としてシャンプー、リンス、ヘアトリートメント、整髪料、ヘアトニック、育毛剤、スキャルプトリートメント等とすることができる。また、硬膏剤、軟膏剤、パップ剤、リニメント剤、ローション剤、塗布剤、貼付剤、エアゾール剤（スプレー薬）とすることができる。 The composition of the present invention can also be prepared into compositions of various dosage forms such as a solid agent, a semisolid agent, and a liquid agent depending on the purpose of use. More specifically, the composition of the present invention can be used as a basic cosmetic, cleansing, facial cleanser, lotion, milk, cream, massage product, pack product, serum / gel, lip care product, etc .; , Face powder, makeup base, concealer, etc .; point makeup cosmetics, lipstick, lip gloss liner, teak products, eye shadow, eyeliner, mascara, eyebrow products, etc .; body cosmetics, soap, liquid cleanser, sun cream Bath cosmetics, etc .; shampoo, rinse, hair treatment, hair conditioner, hair tonic, hair restorer, scalp treatment, etc. as hair cosmetics or scalp cosmetics. Moreover, it can be set as a plaster, an ointment, a poultice, a liniment, a lotion, a coating agent, a patch, an aerosol (spray).
本発明の組成物はまた、キットまたはコマーシャルパッケージとすることができる。これらの態様は、本発明の組成物以外に、使用方法や上述したような目的の効果・効能が記載されたもの（例えば、箱、容器、ラベル、使用説明書、タグ）を含んでもよい。 The composition of the present invention can also be a kit or commercial package. These aspects may include, in addition to the composition of the present invention, a method (for example, a box, a container, a label, an instruction manual, and a tag) on which the method of use and the above-described effects and effects are described.
本発明の剤またはそれを添加した皮膚外用剤もしくは化粧料は、抗酸化により、または細胞内酸化ストレス抑制により改善される状態の処置のため、例えば、肌の抗老化、育毛、美容のために用いることができる。本発明で「育毛」というときは、特に記載した場合を除き、脱毛および／または薄毛の予防・防止、発毛の促進、養毛、毛髪の伸びを速めること、発毛、育毛の目的で頭皮および／または頭髪にうるおいを与えること、および育毛の目的で皮膚をすこやかに保つことを含む。 The agent of the present invention or a skin external preparation or cosmetic to which the agent is added is used for treatment of a condition improved by antioxidation or by suppressing intracellular oxidative stress, for example, for anti-aging of skin, hair growth, and cosmetics. Can be used. The term “hair growth” in the present invention, unless otherwise specified, scalp for the purposes of hair loss and / or prevention / prevention of thinning hair, promotion of hair growth, hair growth, speeding hair growth, hair growth, and hair growth. And / or moisturizing the hair and keeping the skin healthy for hair growth purposes.
本発明で「美容（方法）」というときは、特に記載した場合を除き、ヒトに対する医療行為（医師法により、医師および医師の指示を受けた看護師・助産師などの医療従事者のみ行うことが認められている治療や処置。）を含まない。また「皮膚」または「肌」というときは、特に記載した場合を除き、その場所は限定されず、頭皮を含む体表面のあらゆる皮膚を含む。本発明の抗老化のための方法、育毛方法、美容方法は、他人に対して実施する場合を含む。本発明はまた、フウ属植物抽出物を添加・強化する工程を含む、抗酸化剤若しくは細胞内酸化ストレス抑制剤、または皮膚外用剤もしくは化粧料の製造方法を提供する。本発明でフウ属植物抽出物を化粧料等に「添加する工程」というときは、化粧料等の商業的な製造において、フウ属植物抽出物を原料として用いることを含む。本発明の方法は、医師（医師の指示を受けた看護師・助産師などの医療従事者も含む。）以外の者、例えば、化粧品または医薬品の製造者、販売者、メイクアップ・アーティスト、美容スタッフ、またはエステティシャン等が行うことができる。 The term “beauty (method)” in the present invention, unless otherwise specified, is to be performed only by medical personnel (medical doctors, nurses and midwives who have received instructions from doctors in accordance with the Doctor Law). Is not included.) In addition, the term “skin” or “skin” is not limited unless specifically described, and includes any skin on the body surface including the scalp. The method for anti-aging, the hair-growth method, and the beauty method of the present invention includes a case where the method is carried out on another person. The present invention also provides a method for producing an antioxidant, an intracellular oxidative stress inhibitor, or an external preparation for skin or a cosmetic, which comprises a step of adding and strengthening a Fusarium plant extract. In the present invention, the “adding step” of the genus plant extract to a cosmetic or the like includes using the plant genus plant extract as a raw material in the commercial production of the cosmetic or the like. The method of the present invention can be applied to a person other than a doctor (including a medical worker such as a nurse / midwife who has received an instruction from the doctor), such as a manufacturer or seller of cosmetics or pharmaceuticals, a makeup artist, or a beauty. It can be done by staff or estheticians.
以下、実施例を挙げて本発明を更に具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated further more concretely, the scope of the present invention is not limited to the following Example.
［製造例1］
乾燥したフウ（Liquidambar formosana）の幹10gを細切し、メタノール100mLに浸漬し攪拌しながら24時間抽出を行った。抽出液をろ過分離した後、ロータリーエバポレーターを用いて濃縮し、凍結乾燥して抽出物を得た。収量は0.72g（収率7.2％）であった。
[Production Example 1]
10 g of dried hum (Liquidambar formosana) trunk was cut into small pieces, immersed in 100 mL of methanol, and extracted with stirring for 24 hours. The extract was separated by filtration, concentrated using a rotary evaporator, and lyophilized to obtain an extract. The yield was 0.72 g (yield 7.2%).
［製造例2］
乾燥したフウ（Liquidambar formosana）の葉10gを細切し、メタノール100mLに浸漬し攪拌しながら24時間抽出を行った。抽出液をろ過分離した後、ロータリーエバポレーターを用いて濃縮し、凍結乾燥して抽出物を得た。収量は0.87g（収率8.7％）であった。
[Production Example 2]
10 g of dried leaf (Liquidambar formosana) leaf was cut into small pieces, immersed in 100 mL of methanol and extracted for 24 hours with stirring. The extract was separated by filtration, concentrated using a rotary evaporator, and lyophilized to obtain an extract. The yield was 0.87 g (yield 8.7%).
［製造例3］
乾燥したフウ（Liquidambar formosana）の幹10gを細切し、50％エタノール水溶液100mLに浸漬し攪拌しながら24時間抽出を行った。抽出液をろ過分離した後、ロータリーエバポレーターを用いて濃縮し、凍結乾燥して抽出物を得た。収量は0.64g（収率6.4％）であった。
[Production Example 3]
10 g of dried hum (Liquidambar formosana) trunk was cut into small pieces, immersed in 100 mL of 50% ethanol aqueous solution, and extracted for 24 hours with stirring. The extract was separated by filtration, concentrated using a rotary evaporator, and lyophilized to obtain an extract. The yield was 0.64 g (6.4% yield).
［製造例4]
乾燥したフウ（Liquidambar formosana）の果実10ｇを細切し、50％エタノール水溶液100mLに浸漬し攪拌しながら24時間抽出を行った。抽出液をろ過分離した後、ロータリーエバポレーターを用いて濃縮し、凍結乾燥して抽出物を得た。収量は1.0g（収率10.0％）であった。
[Production Example 4]
10 g of dried fruit (Liquidambar formosana) fruit was chopped, soaked in 100 mL of 50% ethanol aqueous solution and extracted for 24 hours with stirring. The extract was separated by filtration, concentrated using a rotary evaporator, and lyophilized to obtain an extract. The yield was 1.0 g (yield 10.0%).
[製造例5]
乾燥したモミジバフウ（Liquidambar styraciflua）の葉10ｇを細切し、50％エタノール水溶液100mLに浸漬し攪拌しながら24時間抽出を行った。抽出液をろ過分離した後、ロータリーエバポレーターを用いて濃縮し、凍結乾燥して抽出物を得た。収量は0.58g（収率5.8％）であった。
[Production Example 5]
10 g of dried dried leaf (Liquidambar styraciflua) leaves were cut into small pieces, immersed in 100 mL of 50% aqueous ethanol, and extracted for 24 hours with stirring. The extract was separated by filtration, concentrated using a rotary evaporator, and lyophilized to obtain an extract. The yield was 0.58 g (yield 5.8%).
［比較例1］
抗酸化効果の知られるマツ属の抽出物を比較対象とした。クロマツ（Pinus thunbergii）の幹10gを細切し、製造例1の方法に従って抽出物を行い比較例1の抽出物を得た。収量は0.91g（収率9.1％）であった。
[Comparative Example 1]
A pine genus extract with known antioxidant effect was used as a comparison target. A pine (Pinus thunbergii) trunk (10 g) was chopped and extracted according to the method of Production Example 1 to obtain an extract of Comparative Example 1. The yield was 0.91 g (yield 9.1%).
［試験方法］
本方法は細胞内ROSと反応し蛍光を発する2',7'-Dichlorofuorescein diacetate（DCFH-DA）を用いるものであり、後掲非特許文献1に記載の方法を参考にしている。細胞膜透過性の高いDCFH-DAは容易に細胞内に浸透し、細胞内エステラーゼにより脱アセチル化されて非蛍光性のDCFHとして細胞内に滞留する。DCFHは細胞内のROSにより酸化されて蛍光性のDCFへと変換されるため、測定されるDCFの蛍光強度がすなわち細胞内ROS量の指標となる。過酸化水素処理により細胞内ROS量は増加するが、測定試料の直接的な抗酸化作用または、測定試料により細胞自身の抗酸化酵素群が活性化されることによる間接的な作用により細胞内ROSが消去されROS量が低下すると、コントロールと比較した蛍光強度の低下として観測される。
[Test method]
This method uses 2 ′, 7′-Dichlorofuorescein diacetate (DCFH-DA) that reacts with intracellular ROS and emits fluorescence, and refers to the method described in Non-Patent Document 1 below. DCFH-DA having high cell membrane permeability easily penetrates into cells, is deacetylated by intracellular esterase, and remains in the cells as non-fluorescent DCFH. Since DCFH is oxidized and converted into fluorescent DCF by intracellular ROS, the measured fluorescence intensity of DCF is an indicator of the amount of intracellular ROS. Although the amount of intracellular ROS is increased by hydrogen peroxide treatment, the intracellular ROS is increased by direct antioxidant action of the measurement sample or by indirect action caused by activation of the cell's own antioxidant enzymes by the measurement sample. Is erased and the amount of ROS decreases, it is observed as a decrease in fluorescence intensity compared to the control.
非特許文献1：
Kelly L. Wolfe, Rui Hai Liu, Cellular Antioxidant Activity (CAA) Assay for Assessing Antioxidants, Foods, and Dietary Supplements. J Agric Food Chem 2007, 55, p8896
Non-patent document 1:
Kelly L. Wolfe, Rui Hai Liu, Cellular Antioxidant Activity (CAA) Assay for Assessing Antioxidants, Foods, and Dietary Supplements.J Agric Food Chem 2007, 55, p8896
［試験例1］
HepG2細胞を10％FBS含有MEM培地で37℃、5％CO2存在下、1週間培養した。1週間後に0.125％トリプシン−EDTA溶液を用いて細胞を回収して24ウェルプレートに3×105個／cm2の濃度で播種した。37℃、5％CO2存在下で24時間培養した後、各ウェルをPBS（-）で1回洗浄し、新たな培地1mLを加えた。続いて、製造例1〜2のフウ抽出物または比較例1をDMSOに溶解し最終濃度10ug／mLになるように添加した。さらにDCFH-DA（シグマ−アルドリッチジャパン株式会社製）をPBS（-）で希釈して最終濃度25μMになるように加えた。37℃、5％CO2存在下で1時間培養した後に、過酸化水素（和光純薬株式会社製）をPBS（-）で希釈し最終濃度が200μMになるよう添加し、室温暗所で1時間静置した。1時間後に各ウェルをPBS（-）で洗浄し、PBS（-）1mLを加えて励起波長485nmで538nmにおける蛍光強度を測定した。式（1）に従って、細胞内酸化ストレス消去率を算出した。
[Test Example 1]
HepG2 cells were cultured in MEM medium containing 10% FBS at 37 ° C. in the presence of 5% CO 2 for 1 week. One week later, cells were collected using a 0.125% trypsin-EDTA solution and seeded at a concentration of 3 × 10 5 cells / cm 2 in a 24-well plate. After culturing at 37 ° C. in the presence of 5% CO 2 for 24 hours, each well was washed once with PBS (−), and 1 mL of fresh medium was added. Subsequently, the fux extracts of Production Examples 1 and 2 or Comparative Example 1 were dissolved in DMSO and added to a final concentration of 10 ug / mL. Furthermore, DCFH-DA (manufactured by Sigma-Aldrich Japan Co., Ltd.) was diluted with PBS (−) and added to a final concentration of 25 μM. After 1 hour of incubation at 37 ° C in the presence of 5% CO 2 , hydrogen peroxide (Wako Pure Chemical Industries, Ltd.) was diluted with PBS (-) and added to a final concentration of 200 µM. Let stand for hours. After 1 hour, each well was washed with PBS (−), 1 mL of PBS (−) was added, and the fluorescence intensity at 538 nm was measured at an excitation wavelength of 485 nm. Intracellular oxidative stress elimination rate was calculated according to equation (1).
結果を下表および図1に示す。 The results are shown in the table below and FIG.
製造例1〜2のフウ抽出物は比較例1のクロマツ抽出物と比較して細胞内酸化ストレス消去効果が高く、優れた抗酸化作用を有することが示された。 Compared with the black pine extract of Comparative Example 1, the fux extracts of Production Examples 1 and 2 had a higher effect of eliminating intracellular oxidative stress and were shown to have an excellent antioxidant action.
［試験例2：IC50］
HepG2細胞を10％FBS含有MEM培地で37℃、5％CO2存在下、1週間培養した。1週間後に0.125％トリプシン−EDTA溶液を用いて細胞を回収して24ウェルプレートに3×105個／cm2の濃度で播種した。37℃、5％CO2存在下で24時間培養した後、各ウェルをPBS（−）で1回洗浄し、新たな培地1mLを加えた。続いて、製造例3のフウ抽出物をDMSOに溶解し最終濃度がそれぞれ50ug／mL、16.7ug／mL、5.6ug／mL、1.9ug／mL、0.6ug／mL、0.2ug／mL、0.07ug／mL、0.02ug／mLになるように添加した。さらにDCFH−DA（シグマ−アルドリッチジャパン株式会社製）をPBS（−）で希釈して最終濃度25μMになるように加えた。37℃、5％CO2存在下で1時間培養した後に、過酸化水素（和光純薬株式会社製）をPBS（−）で希釈し最終濃度が200μMになるよう添加し、室温暗所で1時間静置した。1時間後に各ウェルをPBS（−）で洗浄し、PBS（−）1mLを加えて励起波長485nmで538nmにおける蛍光強度を測定した。試料の各添加濃度における蛍光強度から（1）式に従って細胞内酸化ストレス消去率を計算し、続いてIC50（細胞内ROS量を半減させるために必要な試料濃度）を算出し比較した。比較対象としてビタミンCおよび水溶性ビタミンE（Trolox： シグマ−アルドリッチジャパン株式会社製）を用いた。
[Test Example 2: IC 50 ]
HepG2 cells were cultured in MEM medium containing 10% FBS at 37 ° C. in the presence of 5% CO 2 for 1 week. One week later, cells were collected using a 0.125% trypsin-EDTA solution and seeded at a concentration of 3 × 10 5 cells / cm 2 in a 24-well plate. After culturing at 37 ° C. in the presence of 5% CO 2 for 24 hours, each well was washed once with PBS (−), and 1 mL of fresh medium was added. Subsequently, the fuxed extract of Production Example 3 was dissolved in DMSO, and final concentrations were 50 ug / mL, 16.7 ug / mL, 5.6 ug / mL, 1.9 ug / mL, 0.6 ug / mL, 0.2 ug / mL, and 0.07 ug, respectively. / ML and 0.02ug / mL were added. Furthermore, DCFH-DA (manufactured by Sigma-Aldrich Japan Co., Ltd.) was diluted with PBS (−) and added to a final concentration of 25 μM. After 1 hour of incubation at 37 ° C. in the presence of 5% CO 2 , hydrogen peroxide (Wako Pure Chemical Industries, Ltd.) was diluted with PBS (−) and added to a final concentration of 200 μM. Let stand for hours. After 1 hour, each well was washed with PBS (−), 1 mL of PBS (−) was added, and the fluorescence intensity at 538 nm was measured at an excitation wavelength of 485 nm. The intracellular oxidative stress extinction rate was calculated from the fluorescence intensity at each added concentration of the sample according to the formula (1), and then IC 50 (sample concentration necessary for halving the intracellular ROS amount) was calculated and compared. Vitamin C and water-soluble vitamin E (Trolox: Sigma-Aldrich Japan Co., Ltd.) were used for comparison.
結果を下表に示した。 The results are shown in the table below.
製造例3のフウ抽出物は抗酸化剤として汎用されているビタミンCやビタミンEと比較してIC50が低く、細胞内においてビタミンCやビタミンEよりも優れた抗酸化作用を示すことが明らかになった。 Production example 3 fu extract has a lower IC 50 than vitamin C and vitamin E, which are widely used as antioxidants, and it is clear that it exhibits an antioxidant effect superior to vitamin C and vitamin E in cells Became.
［処方例］
［化粧水1］
(製法)
A. 下記成分(1)〜(8)を混合溶解する。
B. 下記成分(9)〜(15)を混合溶解する。
C. BにAを加え混合し、化粧水を得る。
(成分)(質量％)
(1)メドウホーム油 0.1
(2)ホホバ油 0.05
(3)香料 適量
(4)フェノキシエタノール 0.1
(5)モノオレイン酸ポリオキシエチレン(20E.O.)ソルビタン 0.5
(6)イソステアリン酸ポリオキシエチレン(50E.O.)硬化ヒマシ油 1.0
(7)エタノール 8.0
(8)酢酸トコフェロール 0.05
(9)グリチルリチン酸ジカリウム 0.1
(10)グリセリン 5.0
(11)1，3−ブチレングリコール 5.0
(12)ポリエチレングリコール1500 0.1
(13)フウ抽出液(＊1) 0.1
(14)加水分解コラーゲン 0.001
(15)精製水 残量
(＊1)製造例3により調製されたもの
[Prescription example]
[Lotion 1]
(Manufacturing method)
A. The following components (1) to (8) are mixed and dissolved.
B. The following components (9) to (15) are mixed and dissolved.
C. Add A to B and mix to obtain lotion.
(Component) (mass%)
(1) Meadow home oil 0.1
(2) Jojoba oil 0.05
(3) Perfume appropriate amount
(4) Phenoxyethanol 0.1
(5) Polyoxyethylene monooleate (20E.O.) sorbitan 0.5
(6) Polyoxyethylene isostearate (50E.O.) hydrogenated castor oil 1.0
(7) Ethanol 8.0
(8) Tocopherol acetate 0.05
(9) Dipotassium glycyrrhizinate 0.1
(10) Glycerin 5.0
(11) 1,3-butylene glycol 5.0
(12) Polyethylene glycol 1500 0.1
(13) Fuso extract (* 1) 0.1
(14) Hydrolyzed collagen 0.001
(15) Purified water remaining
(* 1) Prepared by Production Example 3
［化粧水2］
(製法)
A. 下記成分(1)〜(9)を混合溶解する。
B. 下記成分(10)〜(13)を混合溶解する。
C. AにBを加え混合し、化粧水を得る。
(成分)(質量％)
(1)水酸化ナトリウム 0.3
(2)クエン酸 0.1
(3)リン酸一水素ナトリウム 0.1
(4)エデト酸二ナトリウム 0.05
(5)アスコルビン酸グルコシド 2.0
(6)フウ抽出液(＊2) 0.1
(7)グリセリン 3.0
(8)ジプロピレングリコール 8.0
(9)精製水 残量
(10)エタノール 10.0
(11)香料適量
(12)ポリオキシエチレン硬化ヒマシ油 0.05
(13)テトラ−２−エチルヘキサン酸ペンタエリトリット 0.2
(＊2)製造例4により調製されたもの
[Lotion 2]
(Manufacturing method)
A. The following components (1) to (9) are mixed and dissolved.
B. The following components (10) to (13) are mixed and dissolved.
C. Add B to A and mix to obtain lotion.
(Component) (mass%)
(1) Sodium hydroxide 0.3
(2) Citric acid 0.1
(3) Sodium monohydrogen phosphate 0.1
(4) Disodium edetate 0.05
(5) Ascorbic acid glucoside 2.0
(6) Fuso extract (* 2) 0.1
(7) Glycerin 3.0
(8) Dipropylene glycol 8.0
(9) Purified water remaining
(10) Ethanol 10.0
(11) Appropriate perfume
(12) Polyoxyethylene hydrogenated castor oil 0.05
(13) Tetra-2-ethylhexanoic acid pentaerythritol 0.2
(* 2) Prepared according to Production Example 4.
［乳液］
(製法)
A. 下記成分(11)の一部を加熱し、70℃に保つ。
B. 下記成分(1)〜(10)を加熱混合し、70℃に保つ。
C. BにAを加えて混合し、均一に乳化する。
D. Cを冷却後、下記成分(12)〜(16)と(11)の残部を混合してから加え、均一に混合して乳液を得た。
(成分)(質量％)
(1)ポリオキシエチレン(10E.O.)ソルビタンモノステアレート 1.0
(2)ポリオキシエチレン(60E.O.)ソルビタントリオレエート 0.5
(3)グリセリルモノステアレート 1.0
(4)ステアリン酸 0.5
(5)ベヘニルアルコール 0.5
(6)スクワラン 8.0
(7)エタノール 5.0
(8)パルミチン酸レチノール 0.1
(9)グリチルレチン酸ステアリル 0.1
(10)フェノキシエタノール 0.1
(11)精製水 残量
(12)カルボキシビニルポリマー 0.2
(13)水酸化ナトリウム 0.1
(14)ヒアルロン酸 0.1
(15)フウ抽出液(＊3) 0.03
(16)香料適量
(＊3)製造例5により調製されたもの
[Emulsion]
(Manufacturing method)
A. Heat a part of the following component (11) and keep it at 70 ° C.
B. The following components (1) to (10) are heated and mixed and maintained at 70 ° C.
C. Add A to B, mix, and uniformly emulsify.
After cooling D.C, the following components (12) to (16) and the remainder of (11) were mixed and then added and mixed uniformly to obtain an emulsion.
(Component) (mass%)
(1) Polyoxyethylene (10E.O.) sorbitan monostearate 1.0
(2) Polyoxyethylene (60E.O.) sorbitan trioleate 0.5
(3) Glyceryl monostearate 1.0
(4) Stearic acid 0.5
(5) Behenyl alcohol 0.5
(6) Squalane 8.0
(7) Ethanol 5.0
(8) Retinol palmitate 0.1
(9) Stearyl glycyrrhetinate 0.1
(10) Phenoxyethanol 0.1
(11) Remaining amount of purified water
(12) Carboxyvinyl polymer 0.2
(13) Sodium hydroxide 0.1
(14) Hyaluronic acid 0.1
(15) Fuso extract (* 3) 0.03
(16) Appropriate perfume
(* 3) Prepared according to Production Example 5.
［リキッドファンデーション(水中油型乳液状)］
(製造方法)
A. 成分(6)〜(11)を分散する。
B. Aに成分(12)〜(17)を加え70℃で均一に混合する。
C. 成分(1)〜(5)を70℃で均一に混合する。
D. CにBを加え乳化し、室温まで冷却する。
E. Dに成分(18)、(19)を添加し均一に混合して水中油型クリーム状リキッドファンデーションを得た。
(成分)(質量％)
(1)アクリル酸・メタクリル酸アルキル共重合(注1) 0.5
(2)トリエタノールアミン 1.5
(3)精製水 残量
(4)グリセリン 5
(5)パラオキシ安息香酸メチル 0.1
(6)1，3ブチレングリコール 5
(7)水素添加大豆リン脂質 0.5
(8)テフロン（登録商標）処理酸化チタン 5
(9)オクチルシリル化処理ベンガラ 0.1
(10)シリコーン処理黄酸化鉄 1
(11)無水ケイ酸処理黒酸化鉄 0.05
(12)ステアリン酸 0.9
(13)モノステアリン酸グリセリン 0.3
(14)セトステアリルアルコール 0.4
(15)モノオレイン酸ポリオキシエチレン(20E.O.)ソルビタン 0.2
(16)トリオレイン酸ポリオキシエチレン(20E.O.)ソルビタン 0.2
(17)パラメトキシケイ皮酸2―エチルヘキシル 5
(18)フウ抽出液(＊4) 1
(19)香料 0.02
(＊4)製造例3により調製されたもの
(注1)ペミュレンTR−2(NOVEON社製)
[Liquid Foundation (oil-in-water emulsion)]
(Production method)
A. Disperse components (6) to (11).
B. Add components (12) to (17) to A and mix uniformly at 70 ° C.
C. Ingredients (1) to (5) are uniformly mixed at 70 ° C.
D. Add B to C, emulsify, and cool to room temperature.
Components (18) and (19) were added to ED and mixed uniformly to obtain an oil-in-water cream liquid foundation.
(Component) (mass%)
(1) Acrylic acid / alkyl methacrylate copolymer (Note 1) 0.5
(2) Triethanolamine 1.5
(3) Purified water remaining
(4) Glycerin 5
(5) Methyl paraoxybenzoate 0.1
(6) 1,3 Butylene glycol 5
(7) Hydrogenated soybean phospholipid 0.5
(8) Teflon (registered trademark) treated titanium oxide 5
(9) Octyl silylation treatment Bengala 0.1
(10) Silicone-treated yellow iron oxide 1
(11) Silicic acid-treated black iron oxide 0.05
(12) Stearic acid 0.9
(13) Glycerol monostearate0.3
(14) Cetostearyl alcohol 0.4
(15) Polyoxyethylene monooleate (20E.O.) sorbitan 0.2
(16) Polyoxyethylene trioleate (20E.O.) sorbitan 0.2
(17) 2-methoxyhexyl paramethoxycinnamate 5
(18) Fuso extract (* 4) 1
(19) Fragrance 0.02
(* 4) Prepared according to Production Example 3.
(Note 1) Pemulen TR-2 (NOVEON)
［日焼け止め化粧料(油中水型クリーム状)］
(製造方法)
A. 成分(1)〜(6)を均一に分散する。
B. 成分(7)〜(11)を均一に分散する。
C. 成分(12)〜(16)を均一に分散する。
D. AとBを均一に混合後、徐々にCを加えて乳化し、油中水型クリーム状日焼け止め化粧料を得た。
(成分)(質量％)
(1)シリコン・イソプロピルトリイソステアロイルチタネート処理酸化亜鉛 10
(2)ハイドロゲンジメチコン処理微粒子酸化チタン 5.0
(3)ラウリルPEG-9ポリジメチルシロキシエチルジメチコン 3.5
(4)PEG−9ポリジメチルシロキシエチルジメチコン(注2) 3
(5)デカメチルシクロペンタシロキサン 20
(6)イソノナン酸イソトリデシル 5
(7)パラメトキシケイ皮酸2−エチルヘキシル 8
(8)ジエチルアミノヒドロキシベンゾイルテトラメチルブチルフェノール 3.5
(9)ジメチルステアリルアンモニウムヘクトライト 1.2
(10)(ジメチコン/ビニルジメチコン)クロスポリマー 2.5
(11)トコフェロール 0.001
(12)精製水 残量
(13)エタノール 6.5
(14)塩化ナトリウム 0.3
(15)フウ抽出液(＊5) 0.05
(16)アスコルビルリン酸マグネシウム 3
(＊5)製造例4により調製されたもの
(注2)KF−6028(信越化学工業社製)
[Sunscreen cosmetic (water-in-oil cream)]
(Production method)
A. Disperse components (1) to (6) uniformly.
B. Disperse components (7) to (11) uniformly.
C. Disperse components (12) to (16) uniformly.
D. After uniformly mixing A and B, C was gradually added and emulsified to obtain a water-in-oil cream sunscreen cosmetic.
(Component) (mass%)
(1) Zinc oxide treated with silicon isopropyl triisostearoyl titanate 10
(2) Hydrogen dimethicone-treated fine particle titanium oxide 5.0
(3) Lauryl PEG-9 polydimethylsiloxyethyl dimethicone 3.5
(4) PEG-9 polydimethylsiloxyethyl dimethicone (Note 2) 3
(5) Decamethylcyclopentasiloxane 20
(6) Isotridecyl isononanoate 5
(7) 2-Ethylhexyl paramethoxycinnamate 8
(8) Diethylaminohydroxybenzoyltetramethylbutylphenol 3.5
(9) Dimethylstearyl ammonium hectorite 1.2
(10) (Dimethicone / Vinyl Dimethicone) Cross Polymer 2.5
(11) Tocopherol 0.001
(12) Remaining amount of purified water
(13) Ethanol 6.5
(14) Sodium chloride 0.3
(15) Fuso extract (* 5) 0.05
(16) Magnesium ascorbyl phosphate 3
(* 5) Prepared according to Production Example 4.
(Note 2) KF-6028 (manufactured by Shin-Etsu Chemical Co., Ltd.)
［軟膏剤］
(製造方法)
A. 成分(1)〜(4)を加熱混合し、75℃に保つ。
B. 成分 (5)〜(9)を加熱混合し、75℃に保つ。
C. AにBを徐々に加え軟膏剤を得た。
(成分)(質量％)
(1)ステアリン酸 18.0
(2)セタノール 4.0
(3)酢酸dl−α―トコフェロール(注3) 0.2
(4)パラオキシ安息香酸メチル 0.1
(5)トリエタノールアミン 2.0
(6)グリセリン 5.0
(7)グリチルリチン酸ジカリウム(注4) 0.5
(8)フウ抽出液(＊6) 0.1
(9)精製水 残量
(＊6)製造例5により調製されたもの
(注3)エーザイ社製
(注4)和光純薬工業社製
[Ointment]
(Production method)
A. Ingredients (1) to (4) are heated and mixed and kept at 75 ° C.
B. Ingredients (5)-(9) are heated and mixed and kept at 75 ° C.
C. B was gradually added to A to obtain an ointment.
(Component) (mass%)
(1) Stearic acid 18.0
(2) Cetanol 4.0
(3) dl-α-tocopherol acetate (Note 3) 0.2
(4) Methyl paraoxybenzoate 0.1
(5) Triethanolamine 2.0
(6) Glycerin 5.0
(7) Dipotassium glycyrrhizinate (Note 4) 0.5
(8) Fuso extract (* 6) 0.1
(9) Purified water remaining
(* 6) Prepared according to Production Example 5.
(Note 3) Made by Eisai
(Note 4) Wako Pure Chemical Industries, Ltd.
［ローション剤］
(製造方法)
A. 成分(4)〜(7)を混合溶解する。
B. 成分(1)〜(3)を混合溶解する。
C. AとBを混合して均一にし、ローション剤を得た。
(成分)(質量％)
(1)グリセリン 5.0
(2)1，3−ブチレングリコール 6.5
(3)精製水 残量
(4)ポリオキシエチレン(20E.O.)ソルビタンモノラウリン酸エステル 1.2
(5)エタノール 8.0
(6)フウ抽出液(＊7) 0.1
(7)パラオキシ安息香酸メチル 0.2
(＊7)製造例3により調製されたもの
[Lotion]
(Production method)
A. Components (4) to (7) are mixed and dissolved.
B. Ingredients (1) to (3) are mixed and dissolved.
C. A and B were mixed and homogenized to obtain a lotion preparation.
(Component) (mass%)
(1) Glycerin 5.0
(2) 1,3-butylene glycol 6.5
(3) Purified water remaining
(4) Polyoxyethylene (20E.O.) sorbitan monolaurate ester 1.2
(5) Ethanol 8.0
(6) Fuso extract (* 7) 0.1
(7) Methyl paraoxybenzoate 0.2
(* 7) Prepared according to Production Example 3.
［養毛剤］
(製造方法)
A. 成分(1)〜(5)を混合溶解する。
B. 成分(6)〜(10)を混合溶解する。
C. AとBを混合して均一にし、養毛剤を得た。
(成分)(質量％)
(1)エタノール 50.0
(2)ポリオキシエチレン硬化ヒマシ油(80E.O) 0.5
(3)メントール 0.05
(4)カンファ 0.01
(5)フェノキシエタノール 0.05
(6)精製水 残量
(7)フウ抽出液(＊8) 1
(8)オタネニンジン抽出物(注5) 0.5
(9)パントテニルアルコール(注6) 0.1
(10)グリセリン 5.0
(＊8)製造例4により調製されたもの
(注5)一丸ファルコス社製
(注6)関東化学社製
[Hair nourishing agent]
(Production method)
A. Mix and dissolve components (1) to (5).
B. Mix and dissolve components (6) to (10).
C. A and B were mixed and uniformed to obtain a hair nourishing agent.
(Component) (mass%)
(1) Ethanol 50.0
(2) Polyoxyethylene hydrogenated castor oil (80E.O) 0.5
(3) Menthol 0.05
(4) Camphor 0.01
(5) Phenoxyethanol 0.05
(6) Remaining amount of purified water
(7) Fuso extract (* 8) 1
(8) Panax ginseng extract (Note 5) 0.5
(9) Pantothenyl alcohol (Note 6) 0.1
(10) Glycerin 5.0
(* 8) Prepared by Production Example 4
(Note 5) Made by Ichimaru Falcos
(Note 6) Made by Kanto Chemical Co., Inc.
本発明によれば、天然物由来の、抗酸化剤（特に生体内抗酸化剤）、細胞内酸化ストレス抑制剤、並びにそれらを含む皮膚外用剤、抗老化のための化粧品、育毛剤が提供される。 ADVANTAGE OF THE INVENTION According to this invention, the antioxidant (especially in-vivo antioxidant) derived from a natural product, the intracellular oxidative stress inhibitor, the skin external preparation containing them, the cosmetics for anti-aging, and the hair restorer are provided. The
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013042626A JP6170314B2 (en) | 2013-03-05 | 2013-03-05 | Antioxidants with fu extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013042626A JP6170314B2 (en) | 2013-03-05 | 2013-03-05 | Antioxidants with fu extract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014169256A JP2014169256A (en) | 2014-09-18 |
| JP6170314B2 true JP6170314B2 (en) | 2017-07-26 |
Family
ID=51691947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013042626A Expired - Fee Related JP6170314B2 (en) | 2013-03-05 | 2013-03-05 | Antioxidants with fu extract |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6170314B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111849645B (en) * | 2020-08-18 | 2023-04-14 | 南京林业大学 | Multifunctional maple grease essential oil and preparation method and application thereof |
| KR102646678B1 (en) * | 2023-11-30 | 2024-03-13 | 강경아 | An antioxidant, anti-inflammatory, or moisturizing cosmetic composition containing Liquidambaris Fructus extract as an active ingredient |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4567278B2 (en) * | 2001-08-02 | 2010-10-20 | 丸善製薬株式会社 | Skin cosmetics |
| WO2006090935A1 (en) * | 2005-02-28 | 2006-08-31 | Nichirei Foods Inc. | Acerola fruit-derived pectin and use thereof |
| JP2008179632A (en) * | 2006-12-29 | 2008-08-07 | Fuji Chem Ind Co Ltd | Antioxidant |
| JP2010070540A (en) * | 2008-08-22 | 2010-04-02 | Kao Corp | Dgat inhibitor |
| JP2010132629A (en) * | 2008-12-03 | 2010-06-17 | Triple Act:Kk | External composition for skin |
| JP2011162513A (en) * | 2010-02-12 | 2011-08-25 | Sunny Place:Kk | Pomegranate seed extract, pharmaceutical composition, food and drink, and cosmetic thereof, and method for use thereof |
-
2013
- 2013-03-05 JP JP2013042626A patent/JP6170314B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014169256A (en) | 2014-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7275103B2 (en) | Novel cosmetic use of Nephelium lapaceum extract | |
| CN107148264A (en) | Intend Nannochloropsis oculata extract and its application | |
| JP5758174B2 (en) | Antioxidants and antioxidant cosmetics | |
| CN108472322A (en) | Composition containing natural extract and their purposes in skin and hair | |
| CN107530273A (en) | Composition containing Valerian root P.E | |
| JP2013209302A (en) | Agent containing extract of young apple fruits for maintenance of skin stem cells | |
| JP2001097888A (en) | Composition for external use | |
| TW201420127A (en) | Extract of Phalaenopsis amabilis meristem, and the preparation process and uses thereof | |
| JP6170314B2 (en) | Antioxidants with fu extract | |
| JP5770426B2 (en) | Singlet oxygen scavenger, skin external preparation and cosmetic using the singlet oxygen scavenger | |
| JP2013184942A (en) | Antioxidant and dna damage inhibitor | |
| JP2011195539A (en) | Elastase activity inhibitor | |
| JP2015044788A (en) | Epidermal stem cellularity maintenance agent containing acorus calamus extract | |
| JP2004026743A (en) | Polylysine preparation and cosmetic composition containing the same | |
| JP5144362B2 (en) | Topical skin preparation | |
| JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
| JP2011207778A (en) | External preparation for skin or cosmetic | |
| JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
| KR20090075281A (en) | Cosmetic composition with the effect of atopy skins | |
| JP2016108253A (en) | Skin-care cosmetic composition | |
| JP2002068956A (en) | Skin cosmetic | |
| KR102468538B1 (en) | Skin improvement composition containing wild geranium extract with excellent antioxidant, whitening and anti-inflammatory effects | |
| JP2012171877A (en) | Antioxidant, agent for improving skin turgor or sagging, radical scavenger and elastase activity inhibitor | |
| FR3008890B1 (en) | OAK EXTRACT, COMPOSITION COMPRISING SAID EXTRACT AND USES IN PARTICULAR COSMETICS | |
| JP2011032182A (en) | Singlet oxygen quencher, and skin preparation for external use and cosmetic each comprising the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160205 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161115 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170113 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170501 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170606 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170630 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6170314 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |